has announced a presentation from ’s 65th Annual Conference on 9-12 Dec, detailing interim results from the ongoing Phase 2 trial of #bisantrene in R/R AML patients. See link in comments for more.
Don’t see it making a difference to market but important update for RAC.
https://app.sharelinktechnologies.com/announcement/asx/4c5885b4739c498a4c3c55783ce3b52b
General Comments / Chat, page-9822
-
- There are more pages in this discussion • 2,022 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.000(0.00%) |
Mkt cap ! $288.0M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.69 | $1.57 | $387.6K | 237.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 807 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 2376 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |